SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-047081
Filing Date
2023-10-05
Accepted
2023-10-05 08:00:43
Documents
13
Period of Report
2023-10-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20012007_8k.htm   iXBRL 8-K 31635
2 EXHIBIT 99.1 ef20012007_ex99-1.htm EX-99.1 38116
  Complete submission text file 0001140361-23-047081.txt   212264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kron-20231005.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20231005_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20231005_pre.xml EX-101.PRE 16046
7 EXTRACTED XBRL INSTANCE DOCUMENT ef20012007_8k_htm.xml XML 4227
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 231309840
SIC: 2834 Pharmaceutical Preparations